ImmunityBio, Inc. IBRX Non-Controlling Interests
Non-Controlling Interests at other companies
Other financials
Where this comes from
Reported directly by ImmunityBio, Inc. in its filing.
Tagged under the XBRL concept us-gaap:MinorityInterest.
The official record: ImmunityBio, Inc.’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →
Ask your AI about ImmunityBio, Inc.'s non-controlling interests.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is ImmunityBio, Inc.'s non-controlling interests?
- ImmunityBio, Inc. (IBRX) reported non-controlling interests of $880K in Q1 2026.
- How has ImmunityBio, Inc.'s non-controlling interests changed year-over-year?
- ImmunityBio, Inc.'s non-controlling interests decreased by 7.3% year-over-year, from $949K to $880K.
- What is the long-term trend for ImmunityBio, Inc.'s non-controlling interests?
- Over 5 years (2020 to 2025), ImmunityBio, Inc.'s non-controlling interests has grown at a -7.4% compound annual growth rate (CAGR), from $1.32M to $895K.
- What does non-controlling interests mean?
- Equity attributable to minority shareholders in subsidiaries not fully owned by the parent — their proportional claim on subsidiary net assets.